Neuronetics is a privately-held company developing non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. Their NeuroStar TMS Therapy System was developed for treating major depression in patients who have not responded to, or are intolerant of, drug therapy. Neuronetics was founded within The Innovation Factory, an Atlanta, GA-based medical technology incubator.

PropertyValue
dbpedia-owl:Company/industry
dbpedia-owl:Organisation/foundationDate
  • 2003-01-01 00:00:00 (xsd:date)
dbpedia-owl:Organisation/keyPersonPosition
  • Bruce Shook, President & CEO
  • Jim Breidenstein, VP Sales & Customer Service
  • Judy Ways, Ph.D., VP Regulatory Affairs & Quality Assurance
  • Mark Bausinger, CFO
  • Mark Demitrack MD, Chief Medical Officer
  • Mark Riehl, Product Development & Operations
  • Peter Anastasiou, VP Marketing
  • Stanford Miller, VP Health Policy & Access
dbpedia-owl:Organisation/location
dbpedia-owl:Organisation/numberOfEmployees
  • 30 (xsd:integer)
dbpedia-owl:Organisation/type
dbpedia-owl:foundationDate
  • 2003-01-01 00:00:00 (xsd:date)
dbpedia-owl:industry
dbpedia-owl:keyPersonPosition
  • Bruce Shook, President & CEO
  • Jim Breidenstein, VP Sales & Customer Service
  • Judy Ways, Ph.D., VP Regulatory Affairs & Quality Assurance
  • Mark Bausinger, CFO
  • Mark Demitrack MD, Chief Medical Officer
  • Mark Riehl, Product Development & Operations
  • Peter Anastasiou, VP Marketing
  • Stanford Miller, VP Health Policy & Access
dbpedia-owl:location
dbpedia-owl:numberOfEmployees
  • 30 (xsd:integer)
dbpedia-owl:type
dbpprop:abstract
  • Neuronetics is a privately-held company developing non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. Their NeuroStar TMS Therapy System was developed for treating major depression in patients who have not responded to, or are intolerant of, drug therapy. Neuronetics was founded within The Innovation Factory, an Atlanta, GA-based medical technology incubator. The Company has raised significant venture capital on the strength of its unique intellectual property portfolio and experienced management team. Neuronetics’ investors include well-known life-sciences firms such as Quaker BioVentures, Three Arch Partners, Investor Growth Capital, Onset Ventures, Interwest Partners, KBL Healthcare Ventures and Accuitive Medical Ventures.
dbpprop:companyLogo
dbpprop:companyName
  • Neuronetics, Inc.
dbpprop:companyType
dbpprop:foundation
  • 2003 (xsd:integer)
dbpprop:homepage
dbpprop:industry
dbpprop:keyPeople
  • Bruce Shook, President & CEO Mark Bausinger, CFO Mark Demitrack MD, Chief Medical Officer Mark Riehl, Product Development & Operations Peter Anastasiou, VP Marketing Judy Ways, Ph.D., VP Regulatory Affairs & Quality Assurance Stanford Miller, VP Health Policy & Access Jim Breidenstein, VP Sales & Customer Service
dbpprop:location
dbpprop:numEmployees
  • Approximately 30
dbpprop:products
  • NeuroStar TMS Therapy System
dbpprop:reference
dbpprop:wikiPageUsesTemplate
dbpprop:wordnet_type
rdf:type
rdfs:comment
  • Neuronetics is a privately-held company developing non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. Their NeuroStar TMS Therapy System was developed for treating major depression in patients who have not responded to, or are intolerant of, drug therapy. Neuronetics was founded within The Innovation Factory, an Atlanta, GA-based medical technology incubator.
rdfs:label
  • Neuronetics
owl:sameAs
skos:subject
foaf:homepage
foaf:name
  • Neuronetics, Inc.
foaf:page